Quanex Building Products Corporation Stock Price and Value Analysis

Quanex Building Products Corporation (NYSE:NX) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Quanex Building Products Corporation to reach your target.

Target type

NX Free Cash Flow Trend

Free Cash Flow trendline for NX
Free Cash Flow trendline for Quanex Building Products Corporation
CSV

Based on historical returns, we believe that Quanex Building Products Corporation can grow its free cash at a rate of about 6%. That's positive!

AdvantagesDisadvantages
  • This company is making money at a decent rate.
  • This company is solid.
  • This stock is available at a great discount!
  • This company has an average dividend yield.
  • This company has wild ups and downs.

Inside the NX Numbers

NX Price
(Quanex Building Products Corporation stock price per share)
$17.62
[?] NX Fair Price
(based on intrinsic value)
$44.10
[?] NX Safety Price (based on a variable margin of safety) $28.67
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 36% higher than other Basic Materials stocks
[?] PE Ratio versus Industry 0% lower than other Other Industrial Metals & Mining stocks
[?] Cash Yield 8.95%
[?] Free Cash Flow Jitter 48%
[?] Dividend Yield 1.76% (tax impact)
Shares Shorted 2,933,828

Insider Activity Summary

No open-market insider buys or sells are recorded in the six months to 2026-11-22.

The six months before that had 0 buys and 2 sales.

Recent Insider Activity

Open-market buys and sells reported by Quanex Building Products Corporation's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2025-12-17 Teleios Capital Partners GmbH Sell 119,485 $15.94
2025-12-16 Teleios Capital Partners GmbH Sell 80,515 $16.51

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,933,828 shares shorted. With 39,669,097 shares available for purchase and an average trading volume over the past 10 trading days of 464,540, it would take at least 6.3 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1423221 44.8
2010 1423221 73.9
2011 1423221 34.4
2012 1423221 1.8
2013 1423221 16.2
2014 1423221 -10.1
2015 1423221 33.1
2016 1423221 51
2017 1423221 45.1
2018 1423221 72.2
2019 1423221 65.7
2020 1423221 71
2021 1423221 51.5
2022 1423221 71.1
2023 1423221 118
2024 1423221 57.3
2025 1423221 126

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 11 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $928 million against net income of $422 million, or 2.20 times. Net income was negative in 6 of the 17 years, and those years are left out of the ratio.

In 2025, net income was -$251 million and operating cash flow was $165 million, so no ratio is shown for that year.

In 2025, capital expenditures were $62.6 million, 38.0% of operating cash flow of $165 million, which leaves an estimated $102 million after capex. Across the 17 years with reported capex, it averaged 38.6% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 -137 60.5 15.7 n/a
2010 23.1 89.1 14.7 3.86
2011 9.1 52.9 25.3 5.84
2012 -16.5 26.5 42.9 n/a
2013 -11.7 43.5 37.9 n/a
2014 29.2 20.8 33.8 0.71
2015 16.1 67.1 30 4.17
2016 -1.9 87.3 37.2 n/a
2017 18.7 79.8 34.6 4.27
2018 26.6 105 26.5 3.94
2019 -46.7 96.4 24.9 n/a
2020 38.5 101 25.7 2.62
2021 57 78.6 24 1.38
2022 88.3 98 33.1 1.11
2023 82.5 147 37.4 1.78
2024 33.1 88.8 37.1 2.69
2025 -251 165 62.6 n/a

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $729 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $98.1 million, 13.5% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 6 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $99 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $47.2 million, 37.5% of estimated free cash flow of $126 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 51 5.5 n/a 5.5 10.7%
2017 45.1 5.5 n/a 5.5 12.2%
2018 72.2 7 32 39.1 54.1%
2019 65.7 10.6 9.6 20.2 30.7%
2020 71 10.5 7.2 17.8 25.0%
2021 51.5 10.8 11.2 22 42.7%
2022 71.1 10.6 6.6 17.2 24.2%
2023 118 10.6 5.6 16.2 13.8%
2024 57.3 12 n/a 12 20.9%
2025 126 14.9 32.4 47.2 37.5%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $848 million in 2011 and $1,838 million in 2025, a compound annual growth rate of 5.7% over 14 years.

Revenue rose 43.8% from 2024 to 2025.

Our estimated free cash flow was $126 million in 2025, 6.9% of revenue. In 2011 the estimated margin was 4.1%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2011 848 34.4 4.1%
2012 479 1.8 0.4%
2013 555 16.2 2.9%
2014 595 -10.1 -1.7%
2015 646 33.1 5.1%
2016 928 51 5.5%
2017 867 45.1 5.2%
2018 890 72.2 8.1%
2019 894 65.7 7.4%
2020 852 71 8.3%
2021 1,072 51.5 4.8%
2022 1,222 71.1 5.8%
2023 1,131 118 10.4%
2024 1,278 57.3 4.5%
2025 1,838 126 6.9%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $76 million against total liabilities of $1,242 million, or 6.1% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 63.1% of total assets in 2025, compared with 25.3% in 2010, an increase of 37.8 percentage points.

Stockholders equity was $726 million in 2025, compared with $423 million in 2009, a rise of 71.9%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 7.8% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 544 123 n/a 423
2010 591 187 150 441
2011 585 89.6 148 437
2012 590 71.3 168 422
2013 572 49.7 156 416
2014 517 120 96.2 421
2015 566 23.1 170 395
2016 780 25.5 412 369
2017 774 17.5 366 408
2018 743 29 348 395
2019 645 30.9 315 330
2020 692 51.6 336 356
2021 717 40.1 298 420
2022 725 55.1 260 465
2023 831 58.5 286 546
2024 2,320 97.7 1,309 1,011
2025 1,968 76 1,242 726

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $17.62, the price is below what our model can produce for average free cash flow growth between -30 and 60 percent a year, so no implied growth rate is shown. Our model assumes 6.3 percent a year for this stock. This is not a forecast of growth or a price target.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $72.3 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $14.10 below range
Current price $17.62 below range
20 percent above the current price $21.14 -17.8%
Our model (stored fair price) $44.10 6.3%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

At $17.62, the stock is under our safe value of $28.67, against a fair value estimate of $44.10.

Of the 17 fiscal years we can see for Quanex Building Products Corporation under its current filer, 16 show positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $51 million at the start and $100 million most recently.

Free cash flow is volatile from year to year, with a variability measure of 48%.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

The dividend yield for Quanex Building Products Corporation is 1.76%.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 36% above the average for stocks in the Basic Materials sector.

Its trailing P/E ratio is in line with the average for stocks in the Other Industrial Metals & Mining industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1423221.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 1 of the 17 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: NX annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in NX

Does Quanex Building Products Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: NX

This example shows how we apply the Trendshare checklist to NX: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 17.62
    • Market cap: $807M
    • EPS: 0.97
  2. Step 2 — Valuation checks

    • P/E: 18.165
    • FCF yield: 9.0%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.